Mechanical Overloading‐Induced Nanomineral Crystal Perturbation from the Osteochondral Interface: A Potential Initiator of Osteoarthritis
Advanced Science · 2026
DOI: 10.1002/advs.202516893 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Nan Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases and National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital …. Hauptthemen laut MEDLINE: Osteoarthritis, Chondrocytes, Extracellular Matrix, Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Project of China, Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China, Sichuan International Science and Technology Innovation Cooperation Project.
Abstract (Originalsprache)
As a common degenerative joint disease, osteoarthritis (OA) has been thoroughly studied for its pathogenesis, including cell phenotype and histological morphology changes. Yet, the nano‐micro scale spatiotemporal pathological progression, especially its original site and actuating events during OA progression remain largely unknown. Here, we first proposed that interface‐derived nanocrystal fragmentation and ectopic deposition subjected to mechanical overloading may be a potential initiator for OA progression. Ectopic deposition of nanocrystals results in mechanical stiffness of osteochondral interface extracellular matrix (ECM), which subsequently upregulates fibronectin and vitronectin expression from hypertrophic chondrocytes. Hyper‐mineralized vesicles, secreted by hypertrophic chondrocytes, facilitates the ECM bottom‐up mineralization and top‐down degeneration. Furthermore, mechanical overloading removal can block the ECM mineralization and degradation, and effectively reverse the OA pathology. The present work advances our comprehension of the underlying mechanisms of mechanical overloading induced OA progression and offers a foundation for potential OA therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases and National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, P. R. China.
- Department of Orthognathic and TMJ Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, P. R. China.
- Department of Head and Neck Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, Sichuan Cancer Hospital & Institute, Affiliated Cancer Hospital of University of Electronic Science and Technology…
- AO Research Institute Davos, Davos, Switzerland.
ORCID-Profile: Songsong Zhu
Förderung
- National Key R&D Project of China, Ministry of Science and Technology of the People's Republic of China
- National Natural Science Foundation of China
- Sichuan International Science and Technology Innovation Cooperation Project
Zitieren
APA
Jiang, N., Ren, R., Su, Z., Zhou, J., Cao, P., Zhang, S., Li, Z., Li, C., & Zhu, S. (2026). Mechanical Overloading‐Induced Nanomineral Crystal Perturbation from the Osteochondral Interface: A Potential Initiator of Osteoarthritis. Advanced Science. https://doi.org/10.1002/advs.202516893
Vancouver
Jiang N, Ren R, Su Z, Zhou J, Cao P, Zhang S, et al. Mechanical Overloading‐Induced Nanomineral Crystal Perturbation from the Osteochondral Interface: A Potential Initiator of Osteoarthritis. Advanced Science. 2026. doi:10.1002/advs.202516893
BibTeX
@article{Jiang2026,
author = {Jiang, Nan and Ren, Rong and Su, Zhan and Zhou, Jiahao and Cao, Pinyin and Zhang, Sicheng and Li, Zhen and Li, Chao and Zhu, Songsong},
title = {Mechanical Overloading‐Induced Nanomineral Crystal Perturbation from the Osteochondral Interface: A Potential Initiator of Osteoarthritis},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202516893}
}
EUVIMED